nach oben

Erschienen in:

03.04.2018 | Review

Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature

verfasst von: M. Ghilli, M. D. Mariniello, C. Scatena, l. Dosa, G. Traficante, A. Tamburini, C. Caporalini, A. M. Buccoliero, F. Facchini, L. Colizzi, A. Quattrini Li, E. Landucci, G. Manca, A. G. Naccarato, D. Caramella, C. Favre, M. Roncella

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Secretory breast cancer (SBC) is one of the rarest breast cancer (BC), representing the majority of BC in childhood. Nevertheless, it elicits a lot of interest both for the peculiar morphology and the characteristic genetic features. Currently, there is no consensus on optimal treatment strategy. Therefore, it is useful to report every case in order to establish treatment algorithms.

Methods

We describe the case of a 6-year-old boy diagnosed with a SBC, with peculiar genomic and immunohistochemical features. Moreover, we carried out a review of the literature in order to analyze the present state of knowledge about this rare entity.

Results

To the best of our knowledge, there are only 120 cases published in literature, only 32 in males and only 2 younger than 6 years. Furthermore, this one had peculiar genomic and immunohistochemical features. Indeed, even if SBC expresses basal-cell markers, our patient had a triple-negative tumor expressing both basal and luminal cell markers. Furthermore, the boy’s genomic profile revealed not only positivity for the typical SBC’s translocation t(12;15), but also for a 3q28 duplication, found in his father (healthy) and paternal grandfather (with a previous BC). None were positive for BRCA mutation. This locus includes only one gene encoding for a growth factor recently linked to Early Infantile Epileptic Encephalopathy-47 and Idiopathic ventricular tachycardia. Even if the literature does not provide evidence of a pathogenic role it is not possible to exclude a cancer-predisposing activity.

Conclusions

SBC is a rare type of BC, characterized by triple-negative features with an unexpectedly good prognosis. More data are needed to fully understand the behavior of this cancer and genomic profiling could be helpful in improving its diagnosis and management.

Sharma V, Anuragi G, Singh S et al (2015) Secretory carcinoma of the breast: report of two cases and review of the literature. Case Rep Oncol Med. https://doi.org/10.1155/2015/581892 PubMedPubMedCentralCrossRef

Lamovec J, Bracko M (1994) Secretory carcinoma of the breast: light microscopical, immunohistochemical and flow cytometric study. Mod Pathol 7(4):475–479PubMed

Li D, Xiao X, Yang W et al (2012) Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol 25(4):567–575CrossRefPubMed

Cadoo KA, McArdle O, O’Shea AM et al (2012) Management of unusual histologial types of breast cancer. Oncologist 17:1135–1145CrossRefPubMedPubMedCentral

Laè M, Freneaux P, Sastre-Garau X et al (2009) Secretory breast carcinoma with ETV6–NTRK3 fusion gene belong to the basal like carcinoma spectrum. Mod Pathol 22(2):291–298CrossRefPubMed

McDivitt RW, Stewart FW (1966) Breast carcinoma in children. J Am Med Assoc 195:388–390CrossRef

Tavassoli FA, Norris HJ (1980) Secretory carcinoma of the breast. Cancer 45:2404–2413CrossRefPubMed

Horowitz DP, Sharma AS, Connolly E et al (2012) Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast 21:350–353CrossRefPubMed

Jacob JD, Hodge C, Franko J et al (2016) Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol 113(7):721–725CrossRefPubMed

10.

Szanto J, Andras C, Tsakiris J et al (2004) Secretory breast cancer in a 7.5-year old boy. Breast 13:439–442CrossRefPubMed

11.

Lombardi A, Maggi S, Bersigotti L et al (2013) Secretory breast cancer. Case report. G Chir 34(4):125–127PubMedPubMedCentral

12.

Vasudev P, Onuma K (2011) Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med 135(12):1606–1610. https://doi.org/10.5858/arpa.2010-0351-RS CrossRefPubMed

13.

Toll A, Joneja U, Palazzo J (2016) Pathologic spectrum of secretory and mucinous breast lesions. Arch Pathol Lab Med 140(7):644–650. https://doi.org/10.5858/arpa.2015-0250-RA CrossRefPubMed

14.

Roychowdhury M (2018) Secretory carcinoma. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/breastmalignantjuvenile.html. Accessed 14 Mar 2018

15.

Aktepe F, Sarvenov D, Ozmen V (2016) Secretory carcinoma of the breast. J Breast Health 12:174–176CrossRefPubMedPubMedCentral

16.

de Bree E, Askoxylakis J, Giannikaki E et al (2002) Secretory carcinoma of the male breast. Ann Surg Oncol 9(7):663–667CrossRefPubMed

17.

Grabellus F, Worm K, Willruth A et al (2005) ETV6–NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual. Breast 14(1):71–74CrossRefPubMed

18.

Yorozuya K, Takahashi E, Kousaka J et al (2012) A case of estrogen receptor positive secretory carcinoma in a 9-year-old girl with ETV6–NTRK3 fusion gene. Jpn J Clin Oncol 42(3):208–211CrossRefPubMed

19.

Zhou X (2013) Secretory breast carcinoma in a 10 years old boy. Global J Breast Cancer Res 1:24–27

20.

Krings G, Joseph NM, Bean GR et al (2017) Genomic profiling of breast secretory carcinoma reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol 30:1086–1099CrossRefPubMed

21.

Arce C, Cortes-Padilla D, Huntsman DG et al (2005) Secretory carcinoma of the breast containing the ETV6–NTRK3 fusion gene in a male: case report and review of the literature. World J Surg Oncol 3:35CrossRefPubMedPubMedCentral

22.

Tognon C, Knezevich SR, Huntsman D et al (2002) Expression of the ETV6–NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2(5):367–376. https://doi.org/10.1016/S1535-6108(02)00180-0 CrossRefPubMed

23.

Makretsov N, He M, Hayes M et al (2004) A fluorescence in situ hybridization study of ETV6–NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosom Cancer 40:152–157CrossRefPubMed

24.

Bishop JA, Taube JM, Su A et al (2017) Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary glands. Am J Surg Pathol 41(1):62–66CrossRefPubMed

25.

Del Castillo M, Chibon F, Arnould L et al (2015) Secretory breast carcinoma: a histopathologic and genomic spectrum characterized by a joint specific ETV–NTRK3 gene fusion. Am J Surg Pathol 39(11):1458–1467CrossRefPubMed

26.

Euhus DM, Timmons CF, Tomlinson GE (2002) ETV6–NTRK3: Trk-ing the primary event in human secretory breast cancer. Cancer Cell 2:347–348CrossRefPubMed

27.

Lannon CL (2005) Sorensen PH.ETV6–NTRK3: a chimeric protein tyrosine Kinase with transformation activity in multiple cell lineages. Semin Cancer Biol 15(3):215–223CrossRefPubMed

28.

Soyer T, Yaman Bajin I, Orhan D et al (2015) Secretory breast carcinoma in a 6-year-old girl: mastectomy with sentinel lymph node dissection. Pediatr Surg Int 31:677–681CrossRefPubMed

29.

Ding J, Jiang L, Gan Y et al (2015) A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis. Int J Clin Exp Pathol 8(3):3322–3327PubMedPubMedCentral

30.

Li G, Zhong X, Yao J et al (2015) Secretory breast carcinoma in a 41-year-old man with long-term follow-up: a special report. Fut Oncol 11(12):1767–1773CrossRef

31.

Simpson JS, Barson AJ (1969) Breast tumours in infants and children: a 40-year review of cases at a children’s hospital. Can Med Assoc J 101:100–102PubMedPubMedCentral

32.

Karl SR, Ballantine TV, Zairo R (1985) Juvenile secretory carcinoma of the breast. J Pediatr Surg 20:368–371CrossRefPubMed

33.

Vieni S, Cabibi D, Cipolla C et al (2006) Secretory breast carcinoma with metastatic sentinel lymph node. World J Surg Oncol 4:88. https://doi.org/10.1186/1477-7819-4-88 CrossRefPubMedPubMedCentral

34.

Lian J, Wang XJ, Xu EW et al (2017) Secretory breast carcinoma with liver metastasis: report of a case. Zhonghua Bing Li Xue Za Zhi 46(2):124–125PubMed

35.

Yaqoob N, Kayani N, ul Hasan SH (2006) Painless breast lump in an elderly woman. Secretory breast carcinoma in an elderly woman. Arch Pathol Lab Med 130:1073–1074PubMed

36.

Noh WC, Paik NS, Cho KJ et al (2005) Breast mass in a 3-year-old girl: differentiation of secretory carcinoma versus abnormal thelarche by fine needle aspiration biopsy. Surgery 137(1):109–110CrossRefPubMed

37.

Izumi J, Komaki K, Hirokawa M et al (2003) Secretory carcinoma of the breast with a cystically dilated intraductal component: report of a case. Surg Today 33:110–113CrossRefPubMed

38.

Kulkarni MM, Khandeparkar SG, Joshi AR et al (2016) A rare case of multicentric secretory carcinoma of the breast in an adult female with review of literature. Indian J Pathol Microbiol 59:209–211CrossRefPubMed

39.

Beatty SM, Orel SG, Kim P et al (1998) Multicentric secretory carcinoma of the breast in a 35-year-old woman: mammographic appearance and the use of core biopsy in preoperative management. Breast J 4(3):200–203CrossRef

40.

Wang YQ, Wang Y, Zhang JH et al (2014) Secretory breast carcinoma in a 12-year-old girl: a case report. Oncol Lett 8:1635–1637CrossRefPubMedPubMedCentral

41.

Paeng MH, Choi HY, Sung SH et al (2003) Secretory carcinoma of the breast. J Clin Ultrasound 31:425–429CrossRefPubMed

42.

Mun SH, Ko EY, Han BK et al (2008) Secretory carcinoma of the breast: sonographic features. J Ultrasound Med 27:947–954CrossRefPubMed

43.

Murphy JJ, Morzaria S, Gow KW et al (2000) Breast cancer in a 6 years old child. J Pediatr Surg 35:765–767CrossRefPubMed

44.

Oberman HA (1980) Secretory carcinoma of the breast in adults. Am J Surg Pathol 4:465–470CrossRefPubMed

45.

Longo OA, Mosto A, Moran JC et al (1999) Breast carcinoma in childhood and adolescence: case report and review of the literature. Breast J 5:65–69CrossRefPubMed

46.

Osako T, Takeuchi K, Horii R et al (2013) Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis. Histopathology 63:509–519PubMed

47.

Costa NM, Rodrigues H, Pereira H et al (2004) Secretory breast carcinoma-case report and review of the medical literature. Breast 13:353–355CrossRefPubMed

48.

Din NU, Idrees R, Fatima S et al (2013) Secretory carcinoma of the breast: clinicopathologic study of 8 cases. Ann Diagn Pathol 17:54–57CrossRefPubMed

49.

Shui R, Cheng Y, Bai Q et al (2017) Secretory breast carcinoma with a papillary-predominant pattern: an unusual morphological variant. Histopathology 71(3):488–493CrossRefPubMed

50.

Skalovà A, Vanecek T, Sima R et al (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6–NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34:599–608PubMed

51.

Urano M, Nagao T, Miyabe S et al (2015) Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimic by the presence of the ETV6–NTRK3 translocation and novel surrogate markers. Hum Pathol 46:94–103CrossRefPubMed

52.

Connor A, Perez-Ordonez B, Shago M et al (2012) Mammary analogue secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol 36:27–34CrossRefPubMed

53.

Skalovà A (2013) Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity. Head Neck Pathol 7(Suppl 1):S30–S36CrossRefPubMed

54.

Laajili H, Salem AB, Zaidi S et al (2017) Secretory breast carcinoma, a case report and literature review. Open Access Libr J. https://doi.org/10.4236/oalib.1103591 CrossRef

55.

Cabello C, Alvarenga M, Alvarenga CA et al (2012) Case report and review of the literature: secretory breast cancer in a 13-year-old boy-10 years of follow-up. Breast Cancer Res Treat 133:813–820CrossRefPubMed

56.

Lee SG, Jung SP, Lee HY et al (2014) Secretory breast carcinoma: a report of three cases and a review of the literature. Oncol Lett 8:683–686CrossRefPubMedPubMedCentral

57.

Li Q, Zhao Y, Wu G et al (2017) De Novo FGF12 (fibroblast Growth factor 12) functional variation is potentially associated with idiopathic ventricular tachycardia. J Am Heart Assoc. https://doi.org/10.1161/jaha.117.006130 CrossRefPubMedPubMedCentral

58.

Strauss BL, Bratthauer GL, Tavassoli FA (2006) STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types. Hum Pathol 37(5):586–592CrossRefPubMed

59.

Siekierska A, Isrie M, Liu Y et al (2016) Gain-of-function FHF1 mutation causes early-onset epileptic encephalopathy with cerebellar atrophy. Neurology 86(23):2162–2170CrossRefPubMedPubMedCentral

60.

Krausz T, Jenkins D, Grontoft O et al (1989) Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology 14:25–36CrossRefPubMed

61.

Roth JA, Discafani C, O’Malley M (1988) Secretory breast carcinoma in a man. Am J Surg Pathol 12:150–154CrossRefPubMed

62.

Serour F, Gilad A, Kopolovic J et al (1992) Secretory breast cancer in childhood and adolescence: report of a case and review of the literature. Med Pediatr Oncol 20:341–344CrossRefPubMed

63.

Kasami M, Johnson JE, Reynolds VH et al (1997) Segmental resection of secretory carcinoma of the breast in a young woman: 14-year follow-up. Breast 6:383–385CrossRef

64.

Fathi M, Joudi M, Rajabnejad Y et al (2013) Case report: secretory breast cancer in an 11-year-old girl. J Pediatr Surg Case Rep 1:357–358CrossRef

65.

Chowdhury AR, Hossen M, Hussain QM et al (2017) Rare variety of breast cancer in a young girl: a case report. J Case Rep Images Oncol 3:25–28

66.

Montalvo N, Posso V, Redroban L (2016) Secretory carcinoma in a 79-year-old woman: an exceptionally rare type of breast carcinoma. Rare Tumors 8(4):188–190. https://doi.org/10.4081/rt.2016.6650 CrossRef

67.

Li N, Huang M, Yang Y et al (2017) Secretory breast cancer in a 7-year-old girl. Int J Clin Exp Pathol 10(5):6006–6010

68.

Pohar-Marinsek Z, Golouh R (1994) Secretory breast carcinoma in a man diagnosed by fine needle aspiration biopsy. A case report. Acta Cytol 38:446–450PubMed

69.

Kuwabara H, Yamane M, Okada S (1998) Secretory breast carcinoma in a 66 year old man. J Clin Pathol 51:545–547CrossRefPubMedPubMedCentral

70.

Vesoulis Z, Kashkari S (1998) Fine needle aspiration of secretory breast carcinoma resembling lactational changes. A case report. Acta Cytol 42(4):1032–1036CrossRefPubMed

71.

Kameyama K, Mukai M, Iri H et al (1998) Secretory carcinoma of the breast in a 51-year old male. Pathol Int 48:994–997CrossRefPubMed

72.

Chevallier A, Boissy C, Rampal A et al (1999) Secretory carcinoma of the breast. Report of a case in a 9-year old boy. Clin Exp Pathol 47:88–91PubMed

73.

Yildrim E, Turhan N, Pak I et al (1999) Secretory breast carcinoma in a boy. Eur J Surg Oncol 25(1):98–99

74.

Bhagwandeen BS, Fenton L (1999) Secretory carcinoma of the breast in a nine year old boy. Pathology 31:166–168CrossRefPubMed

75.

Titus J, Sillar RW, Fenton LE (2000) Secretory breast carcinoma in a 9-year-old boy. Aust N Z J Surg 70:144–146CrossRefPubMed

76.

Diallo R, Tognon C, Knezevich SR et al (2003) Secretory carcinoma of the breast: a genetically defined carcinoma entity. Verh Dtsch Ges Pathol 87:193–203PubMed

77.

Woto-Gaye G, Kasse AA, Dieye Y et al (2004) Secretory breast carcinoma in a man. A case report with rapid evolution unfavorable. Ann Pathol 24:432–435CrossRefPubMed

78.

Kavalakat AJ, Covilakam RK, Culas TB (2004) Secretory carcinoma of the breast in a 17-year-old male. World J Surg Oncol 2:17CrossRefPubMedPubMedCentral

79.

Niveditha SR, Bajaj P, Nangia A (2004) Secretory carcinoma of the male breast. J Clin Pathol 57:894CrossRefPubMedPubMedCentral

80.

Alenda C, Aranda FI, Segui FJ et al (2005) Secretory carcinoma of the male breast: correlation of aspiration cytology and pathology. Diagn Cytopathol 32:47–50CrossRefPubMed

81.

Iglesias B, Monteagudo B, Rouco JS et al (2009) Secretory breast carcinoma in a 63-year-old man. J Cutan Pathol 36(Suppl 1):86–88CrossRefPubMed

82.

Gabal S, Talaat S (2011) Secretory carcinoma of male breast: case report and review of the literature. Int J Breast Cancer. https://doi.org/10.4061/2011/704657 PubMedPubMedCentralCrossRef

Titel: Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature
verfasst von: M. Ghilli
M. D. Mariniello
C. Scatena
l. Dosa
G. Traficante
A. Tamburini
C. Caporalini
A. M. Buccoliero
F. Facchini
L. Colizzi
A. Quattrini Li
E. Landucci
G. Manca
A. G. Naccarato
D. Caramella
C. Favre
M. Roncella
Publikationsdatum: 03.04.2018
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-018-4772-4

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer

Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient–provider interactions

Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie